Genetic Analysis of Acid β-Glucosidase in Patients with Multiple Myeloma from Central Taiwan: A Small-Cohort Case-Control Study

Abstract

<b><i>Introduction:</i></b> Multiple myeloma (MM) is an incurable, biologically heterogeneous disease of the plasma cells, associated with older age and is more common in men. Gaucher disease, caused by mutation in acid β-glucosidase (glucocerebrosidase, <i>GBA</i>) gene, has been linked to multiple cancers, especially MM. Pathological accumulation of glucosylceramide and complex glycosphingolipids coupled with chronic inflammation may be the cause of cancer in patients with Gaucher disease. In this study, we hypothesized patients with MM have mutations in the <i>GBA</i> gene and analyzed patients with MM to determine whether they have a higher frequency of <i>GBA</i> variants. <b><i>Methods:</i></b> Twenty-four MM samples were acquired from the Human Biobank, China Medical University Hospital, Taichung, Taiwan. <i>GBA</i> mutations were detected by polymerase chain reaction-directed DNA sequencing. <b><i>Results:</i></b> We found no mutations in the coding regions of <i>GBA</i> in any of the 24 study subjects. However, two single-nucleotide polymorphisms, rs2070679 and rs2361534, were identified. A significant difference was observed between the study and control groups (<i>p</i> = 0.0028) in rs2361534 allele distribution, with the C allele frequency being higher in patients (1/48, 2.1%) than in the control group (5/3030, 0.16%, Taiwan Biobank). <b><i>Conclusion:</i></b> In this study, the sample size was limited and GBA enzyme activity was not measured; therefore, we could not establish a direct correlation between MM and <i>GBA</i> mutations. However, the association of rs2361534 suggests that regions around this single-nucleotide polymorphism may be involved in MM. The relationship between MM and <i>GBA</i> mutations remains unclear. A large sample is required for a detailed analysis of this potential relationship.